Kyle Gano, CEO: Neurocrine Biosciences NBIX Sell · Filed 01/20

Trade details

Type: Insider sale
Amount: $240,470.52
Shares · price: 1,812 sh · $132.71 a share
Held after: 140,407 sh
Stock: Neurocrine Biosciences NBIX
Person: Kyle GanoCEO
Trade date: 26/01/16
Filed: 26/01/20
Days to filing: 4 days

Sold 1.3% of holdings

Share of holding sold: 1.3%

Neurocrine Biosciences trades, last 26 weeks

What else happened in Neurocrine Biosciences around then

Filed or reported within 30 days of the trade day · 25/12/17~02/15

Kyle Gano's recent trades

Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$4.6M
34,588 sh
$4.6M
Filed 01/20
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$4.9M
36,400 sh
$4.9M
Filed 01/16
Traded 01/16
Kyle GanoCEO
Planned sale10b5-1 planNeurocrine Biosciences
Planned sale10b5-1 plan
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/05
Traded 25/11/04
Kyle GanoCEO
SellNeurocrine Biosciences
Sell
Neurocrine Biosciences
NBIX
$42.6K
300 sh
$42.6K
Filed 25/11/04
Traded 25/11/04
Kyle GanoCEO
Sell10b5-1 planNeurocrine Biosciences
Sell10b5-1 plan
Neurocrine Biosciences
NBIX
$158K
1,352 sh
$158K
Filed 25/02/14
Traded 25/02/13